Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5 participants
INTERVENTIONAL
2021-07-01
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Flow-restricted Resistance Exercise to Promote Muscle Strength and Use in Adults With Incomplete Spinal Cord Injury
NCT06907381
Respiratory Motor Control and Blood Pressure Regulation After Spinal Cord Injury
NCT02396823
The Feasibility and Effects of Low-load Blood-flow Restricted Exercise Following Spinal Cord Injury
NCT03690700
Hybrid-FES Exercise to Prevent Cardiovascular Declines in Acute SCI
NCT02139436
An Exercise Intervention to Reduce Neuropathic Pain and Brain Inflammation After Spinal Cord Injury
NCT04137159
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects Subjects will be recruited through the SCI/D department at the Cleveland VA Medical Center. In brief, the subjects must be between 18 and 55 years of age, at least 1-year post injury and free of cardiovascular or hematological diseases. Subjects must also have enough strength in their lower limbs to walk unassisted for 10 meters (see the complete list of subject inclusion/exclusion criteria in human subjects document). The primary variables for this investigation are changes in muscle strength, cross sectional area and vascular function. Due to the lack of data on BFR exercise in the SCI population, estimates of required sample size for this study were based on previously published BFR data in other clinical populations with musculoskeletal weakness and atrophy. In general, effect size of BFR exercise training on muscle strength and cross sectional from several investigations were 1.13, 0.995 and 1.9. Thus, a priori power analysis indicated that a sample size of 16 participants are needed to provide sufficient statistical to detect a change between pre- and post-training using an alpha of 0.05 and power of 0.80.
Training program: The training program will consist of 8 weeks of either traditional or BFR knee extension/flexion exercise on a Biodex System 3 dynamometer. Subjects will be required to come to the laboratory 2-3 days per week for the duration of the training program with the ultimate' goal of 20 training sessions distributed across each 8-week period. Two recent published review papers indicate that BFR training 2-3 times per week is sufficient for muscular benefits in the clinical populations. BFR training throughout the 8 weeks will consist of the standard BFR protocol (30reps-15reps-15reps-15reps) of knee extension/flexion with 60 seconds of recovery between each set. The dynamometer resistance will be set to 30% of maximal voluntary contraction (determined on initial visit) and a metronome will be used to pace the knee extension/flexion at a rate associated with 180 degrees per second (middle of the knee joint velocity range associated with comfortable walking). Performing resistance knee extension/flexion on the isokinetic dynamometer will result in concentric contractions only (there will be no eccentric phase). Concentric contractions combined with BFR have been reported to increase muscle cross sectional area and strength to a greater extent than eccentric exercise with BFR. Blood flow restriction will be applied through the use of a 6 cm cuff inflated to 70% of the pressure required to occlude limb blood flow at rest (see determining arterial occlusion pressure below). The cuff pressure will be inflated prior to the initial set and remain inflated throughout the entire protocol (exercise and recovery periods). This prescribed training plan for the BFR exercise (ie. frequency of training sessions, number of repetitions within each set, duration of rest between sets, intensity and cuff pressure) is based on recommendations from two recently published systematic reviews of BFR training. The traditional resistance training program will be a standardized exercise protocol used in rehabilitation: 3 sets of knee extension/flexion exercise with the resistance set at 60% MVC. To approximate the overall volume (number of total repetitions x weight) of the BFR protocol, the three sets will consist of 13, 12 and 12 repetitions, respectively. During both 8-week periods, peak torque will be re-evaluated every two weeks and subsequent training loads will be modified based on improvements in peak torque.
Determining arterial occlusion pressure: the pressure to occlude femoral arterial blood flow will be determined on an initial visit. Subjects will sit quietly at rest. A cuff will be placed around their upper thigh and a Doppler/ultrasound machine will be used to obtain an image and blood velocity spectrum of the superficial femoral artery (distal to the cuff). The cuff will then be slowly inflated, approximately 2mmHg every second until the velocity spectrum disappear, indicating the absence of blood flow. The cuff pressure at which blood flow stops will be considered the arterial occlusion pressure.
Potential problems and alternative strategies with training protocol: Due to the wide range of functional capacity in the iSCI population, some subjects may not be able to initially complete the exercise protocol as outlined above. To increase the likelihood that subjects can obtain the prescribed number of total repetitions, especially in the first couple weeks of training, the repetitions within each set and number of sets may be modified (ex 3 sets of 13, 12, 12 repetitions may be replaced by 4 sets of 10, 9, 9, 9 repetitions as this would maintain the overall number of repetitions but add an additional recovery period). Furthermore, training sessions in the initial 8-week period will be well documented such that overall volume can be replicated in the second 8-week training session. Although there is limited experimental evidence suggesting that BFR training carries a higher risk compared to typical high intensity exercise, Spranger and colleagues have previously outlined potential risks associated with BFR exercise in patients with hypertension, heart failure and peripheral artery disease. Specifically, BFR exercise might lead to dangerously high blood pressure responses in those with exaggerated exercise pressor reflexes. However, the SCI population, if anything, would have a reduced exercise pressor reflex due to interrupted afferent feedback from the lower limb. Finally, two 8-week training sessions is a major time commitment for subjects. Thus, the investigators will provide financial reimbursement for participation and attempt to recruit patients who are already visiting the hospital on a regular basis for rehabilitation. If it is still difficult to find subjects who are willing to participate in such a lengthy study the investigators will modify the protocol such that there will be two independent groups of 16 subjects assigned to one of the two interventions (rather than repeated measures) which would require recruitment of more subjects but each subject to participate in only one 8-week training intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
blood flow restriction exercise
8 weeks (20 sessions) of blood flow restriction knee extension/flexion exercise
Blood Flow Restriction exercise
Exercise training will consist of blood flow restriction exercise. Specifically blood pressure cuff will be wrapped around the most proximal portion of the thigh and inflated to a pressure that is 80% of the pressure required to completely occlude femoral blood flow. With the cuff inflated the subject will perform a series of knee extension/flexion exercise protocol. This consists of 30 reps, 15 reps, 15 reps and 15 reps all separated by 1 minute of recovery. All reps will be performed at 30% of the subjects 1 repetition max. This will be preformed 20 times over 8 weeks.
traditional resistance exercise
8 weeks (20 sessions) of traditional knee extension/flexion resistance exercise
Traditional resistance exercise
Traditional knee extension/flexion exercise will be performed. This will consist of a series of 13 reps, 12 reps, 12 reps with 1 minute recovery between each set. The resistance will be set at 60% of their 1 repetition max. This will be performed 20 times across 8 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood Flow Restriction exercise
Exercise training will consist of blood flow restriction exercise. Specifically blood pressure cuff will be wrapped around the most proximal portion of the thigh and inflated to a pressure that is 80% of the pressure required to completely occlude femoral blood flow. With the cuff inflated the subject will perform a series of knee extension/flexion exercise protocol. This consists of 30 reps, 15 reps, 15 reps and 15 reps all separated by 1 minute of recovery. All reps will be performed at 30% of the subjects 1 repetition max. This will be preformed 20 times over 8 weeks.
Traditional resistance exercise
Traditional knee extension/flexion exercise will be performed. This will consist of a series of 13 reps, 12 reps, 12 reps with 1 minute recovery between each set. The resistance will be set at 60% of their 1 repetition max. This will be performed 20 times across 8 weeks.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* As the aim of this investigation is to focus on muscular and vascular adaptations to BFR exercise in the lower limbs, the level of injury must be between C3-L1
Exclusion Criteria
* Individuals required to have ventilator assist devices
* Individuals with significant active systemic disease, e.g. heart disease, renal failure/insufficiency and uncontrolled diabetes, uncontrolled hypertension and blood disorders that increase the risk for clot formation.
* Individuals with chronic inflammatory disease states (i.e. multiple sclerosis or rheumatoid arthritis, Guillen-Barre syndrome, chronic inflammatory demyelinating disorder and acute amyotrophic lateral sclerosis)
* Obese patients (\>30% body fat based on skinfold measurements)
* History of repeated DVTs or a DVT within the last year.
* Individuals currently taking vasodilators
* Individuals with orthopaedic limitations that would prevent them from performing knee extension/flexion exercise (with the exception of decreased strength due to the SCI)
* Individuals with uncontrolled spasticity or a history of frequent autonomic dysreflexia
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John McDaniel, PhD
Role: PRINCIPAL_INVESTIGATOR
Louis Stokes VA Medical Center, Cleveland, OH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Louis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1IO1RX003562-01A1
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
B3562-R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.